In Silico Evaluation of CRISPR-Based Assays for Effective Detection of SARS-CoV-2.
Ontology highlight
ABSTRACT: Coronavirus disease (COVID-19) caused by the SARS-CoV-2 has been an outbreak since late 2019 up to now. This pandemic causes rapid development in molecular detection technologies to diagnose viral infection for epidemic prevention. In addition to antigen test kit (ATK) and polymerase chain reaction (PCR), CRISPR-based assays for detection of SARS-CoV-2 have gained attention because it has a simple setup but still maintain high specificity and sensitivity. However, the SARS-CoV-2 has been continuing mutating over the past few years. Thus, molecular tools that rely on matching at the nucleotide level need to be reevaluated to preserve their specificity and sensitivity. Here, we analyzed how mutations in different variants of concern (VOC), including Alpha, Beta, Gamma, Delta, and Omicron str
SUBMITTER: Kaewsapsak P
PROVIDER: S-EPMC9506389 | biostudies-literature | 2022 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA